Chembio Receives FDA Emergency Use Authorization for the First Rapid Zika IgM Test
Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious disease…
Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious disease…
A new, faster and safer way of diagnosing the Ebola virus has been developed by an academic from N…
MIT researchers have developed a paper-based test that can diagnose Zika infection within 20 minut…
Bruker announced the closing of its acquisition of MERLIN Diagnostika GmbH, located near Bonn, Ger…
iBio, Inc., with its subsidiary, iBio CDMO LLC in Bryan/College Station, Texas, has partnered with…
An innovative, rapid test for meningitis is now being used at Worcester hospital which speeds up d…
The city-based Transasia Bio-Medicals Ltd has introduced the ErbaQik range of rapids for dengue an…
Biosynth, a global company supplying intermediate chemicals to the life science industry and Tel A…